SOLV vs WAY
SOLV: A diversified healthcare technology and medical products company formed to drive innovation in clinical care, dental health, and health information management. WAY: Waystar provides a cloud-based software platform that automates and optimizes revenue cycle management for healthcare providers.
Side-by-side fundamentals
| Metric | SOLV | WAY | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $85.44 | $21.11 | |
| Market cap as of 2026-08-03 | $14.8B | $4.0B | |
| P/E as of 2026-08-03 | 10.47 | 31.49 | SOLV lower |
| PEG as of 2026-08-03 | 0.04 | 1.94 | SOLV lower |
| Net margin as of 2026-08-03 | +17.3% | +10.9% | SOLV higher |
| Gross margin as of 2026-08-03 | +53.7% | +68.7% | WAY higher |
| Operating margin as of 2026-08-03 | +24.5% | +22.9% | SOLV higher |
| ROE as of 2026-08-03 | +30.7% | +3.5% | SOLV higher |
| ROA as of 2026-08-03 | +10.0% | +2.4% | SOLV higher |
| Debt / equity as of 2026-08-03 | 1.06 | 0.37 | WAY lower |
| Revenue growth (YoY) as of 2026-08-03 | -0.6% | +18.6% | WAY higher |
| Revenue CAGR (3y) SEC XBRL | +0.8% | +16.0% | WAY higher |
| Beta as of 2026-08-03 | 0.85 | 0.75 | |
| 1-year return as of 2026-07-31 close | +19.7% | -42.9% | SOLV higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.